128 related articles for article (PubMed ID: 3129900)
1. Acute oligo-anuria during ovarian hyperstimulation syndrome.
Demey HE; Daelemans R; Galdermans D; Verpooten GA; De Broe ME; Bossaert LL
Acta Obstet Gynecol Scand; 1987; 66(8):741-3. PubMed ID: 3129900
[TBL] [Abstract][Full Text] [Related]
2. Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome.
Balasch J; Carmona F; Llach J; Arroyo V; Jové I; Vanrell JA
Hum Reprod; 1990 Apr; 5(3):348-51. PubMed ID: 2112558
[TBL] [Abstract][Full Text] [Related]
3. Nonsurgical management of ectopic pregnancy associated with severe hyperstimulation syndrome.
Chotiner HC
Obstet Gynecol; 1985 Nov; 66(5):740-3. PubMed ID: 3932909
[TBL] [Abstract][Full Text] [Related]
4. Management of hyperstimulation syndrome.
Shapiro AG; Thomas T; Epstein M
Fertil Steril; 1977 Mar; 28(3):237-9. PubMed ID: 838096
[TBL] [Abstract][Full Text] [Related]
5. [The hyperstimulation syndrome].
Kleinstein J
Gynakologe; 1991 Jun; 24(3):130-5. PubMed ID: 1909990
[No Abstract] [Full Text] [Related]
6. Induction of ovulation with human menopausal gonadotropin; with special reference to ovarian hyperstimulation syndrome and hormone excretion.
Narita O; Shimosuka Y; Suzuki M; Kimura T; Goto T; Higashide K; Tomoda Y
Nagoya J Med Sci; 1980 Nov; 43(1-2):7-13. PubMed ID: 6789210
[No Abstract] [Full Text] [Related]
7. Multiple cerebral infarctions associated with ovarian hyperstimulation syndrome.
Yoshii F; Ooki N; Shinohara Y; Uehara K; Mochimaru F
Neurology; 1999 Jul; 53(1):225-7. PubMed ID: 10408568
[TBL] [Abstract][Full Text] [Related]
8. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin.
Tulandi T; McInnes RA; Arronet GH
Int J Fertil; 1984; 29(2):113-7. PubMed ID: 6148315
[TBL] [Abstract][Full Text] [Related]
9. Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney.
Pereira N; Lekovich JP; Kligman I; Rosenwaks Z
Gynecol Endocrinol; 2017 Aug; 33(8):593-597. PubMed ID: 28440686
[TBL] [Abstract][Full Text] [Related]
10. Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient.
Levy T; Orvieto R; Homburg R; Peleg D; Dekel A; Ben-Rafael Z
Hum Reprod; 1996 Jun; 11(6):1177-9. PubMed ID: 8671418
[TBL] [Abstract][Full Text] [Related]
11. Liver dysfunction in ovarian hyperstimulation syndrome. A case report.
Sueldo CE; Price HM; Bachenberg K; Steinleitner A; Gitlin N; Swanson J
J Reprod Med; 1988 Apr; 33(4):387-90. PubMed ID: 3130483
[TBL] [Abstract][Full Text] [Related]
12. Persistent ovarian cysts following administration of human menopausal and chorionic gonadotropins: an attenuated form of ovarian hyperstimulation syndrome.
Tummon IS; Henig I; Radwanska E; Binor Z; Rawlins R; Dmowski WP
Fertil Steril; 1988 Feb; 49(2):244-8. PubMed ID: 3123275
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of the ovarian hyperstimulation syndrome.
Haning RV; Strawn EY; Nolten WE
Obstet Gynecol; 1985 Aug; 66(2):220-4. PubMed ID: 3927208
[TBL] [Abstract][Full Text] [Related]
14. Correct timing of administration of diuretic agents for the treatment of ovarian hyperstimulation syndrome.
Bar-Hava I; Homburg R
Gynecol Endocrinol; 1993 Mar; 7(1):63-5. PubMed ID: 8506765
[No Abstract] [Full Text] [Related]
15. Abortion rate in pregnancies following ovulation induced by human menopausal gonadotropin/human chorionic gonadotropin.
Ben-Rafael Z; Dor J; Mashiach S; Blankstein J; Lunenfeld B; Serr DM
Fertil Steril; 1983 Feb; 39(2):157-61. PubMed ID: 6401634
[TBL] [Abstract][Full Text] [Related]
16. Ovulation induction. Effects of ovulation induction with gonadotrophins on the ovary and uterus and their implications for assisted reproduction.
Rojas FJ
Hum Reprod; 1995 Sep; 10(9):2219-24. PubMed ID: 8530638
[No Abstract] [Full Text] [Related]
17. Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation.
Aboulghar MA; Mansour RT; Serour GI; Rhodes CA; Amin YM
J Assist Reprod Genet; 2000 May; 17(5):298-301. PubMed ID: 10976419
[No Abstract] [Full Text] [Related]
18. Absence of teratogenicity of indomethacin in ovarian hyperstimulation syndrome.
Katz Z; Lancet M; Borenstein R; Chemke J
Int J Fertil; 1984; 29(3):186-8. PubMed ID: 6152259
[TBL] [Abstract][Full Text] [Related]
19. Management of severe ovarian hyperstimulation.
Tyack AJ; Ellis JD
Br Med J; 1971 May; 2(5756):263. PubMed ID: 5572388
[No Abstract] [Full Text] [Related]
20. Hydatidiform mole coexisting with a fetus in twin gestation following gonadotrophin induction of ovulation.
Altaras MM; Rosen DJ; Ben-Nun I; Aviram R; Bernheim J; Beyth Y
Hum Reprod; 1992 Mar; 7(3):429-31. PubMed ID: 1587954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
